EDITAS MEDICINE, INC. Investment Income, Net
EDITAS MEDICINE, INC. (EDIT) reported Investment Income, Net of $1.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-05
- EDITAS MEDICINE, INC. investment income, net for the quarter ending 2026-06-30 was $1.37M, a 34.45% decline year-over-year.
- EDITAS MEDICINE, INC. investment income, net for the quarter ending 2026-03-31 was $1.21M, a 55.60% decline year-over-year.
- EDITAS MEDICINE, INC. investment income, net for the quarter ending 2025-12-31 was $1.68M, a 50.58% decline year-over-year.
- EDITAS MEDICINE, INC. investment income, net for the quarter ending 2025-09-30 was $1.83M, a 48.13% decline year-over-year.
- EDITAS MEDICINE, INC. investment income, net for fiscal 2025 was $8.31M, a 48.87% decline from fiscal 2024.
- EDITAS MEDICINE, INC. investment income, net for fiscal 2024 was $16.25M, a 7.48% decline from fiscal 2023.
- EDITAS MEDICINE, INC. investment income, net for fiscal 2023 was $17.57M, a 218.34% increase from fiscal 2022.
- EDITAS MEDICINE, INC. investment income, net for fiscal 2022 was $5.52M, a 809.06% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.37M 10-Q · filed 2026-08-05 | $2.57M 10-Q · filed 2026-08-05 | $4.25M derived: sum of 3 quarters · filed 2026-08-05 | $6.08M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-05 | $2.88M derived: sum of 2 quarters · filed 2026-05-05 | $4.71M derived: sum of 3 quarters · filed 2026-05-05 | $6.80M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.51M derived: sum of 2 quarters · filed 2026-03-09 | $5.59M derived: sum of 3 quarters · filed 2026-08-05 | $8.31M 10-K · filed 2026-03-09 | |
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-10 | $3.92M derived: sum of 2 quarters · filed 2026-08-05 | $6.63M 10-Q · filed 2025-11-10 | $10.03M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $2.09M 10-Q · filed 2026-08-05 | $4.80M 10-Q · filed 2026-08-05 | $8.19M derived: sum of 3 quarters · filed 2026-08-05 | $11.72M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $2.72M 10-Q · filed 2026-05-05 | $6.11M derived: sum of 2 quarters · filed 2026-05-05 | $9.64M derived: sum of 3 quarters · filed 2026-05-05 | $13.93M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.92M derived: sum of 2 quarters · filed 2026-03-09 | $11.22M derived: sum of 3 quarters · filed 2026-03-09 | $16.25M 10-K · filed 2026-03-09 | $14.06M 10-K · filed 2025-03-05 |
| 2024-09-30 | $3.53M 10-Q · filed 2025-11-10 | $7.83M derived: sum of 2 quarters · filed 2025-11-10 | $12.86M 10-Q · filed 2025-11-10 | $17.96M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $4.30M 10-Q · filed 2025-08-12 | $9.33M 10-Q · filed 2025-08-12 | $14.43M derived: sum of 3 quarters · filed 2025-08-12 | $19.58M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $5.04M 10-Q · filed 2025-05-12 | $10.14M derived: sum of 2 quarters · filed 2025-05-12 | $15.28M derived: sum of 3 quarters · filed 2025-05-12 | $19.09M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $10.25M derived: sum of 2 quarters · filed 2025-03-05 | $14.06M derived: sum of 3 quarters · filed 2025-03-05 | $17.57M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $5.14M 10-Q · filed 2024-11-04 | $8.96M derived: sum of 2 quarters · filed 2024-11-04 | $12.46M 10-Q · filed 2024-11-04 | $15.18M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2023-06-30 | $3.81M 10-Q · filed 2024-08-07 | $7.32M 10-Q · filed 2024-08-07 | $10.03M derived: sum of 3 quarters · filed 2025-03-05 | $11.82M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2023-03-31 | $3.51M 10-Q · filed 2024-05-08 | $6.22M derived: sum of 2 quarters · filed 2025-03-05 | $8.01M derived: sum of 3 quarters · filed 2025-03-05 | $8.56M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2022-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $4.50M derived: sum of 2 quarters · filed 2025-03-05 | $5.05M derived: sum of 3 quarters · filed 2025-03-05 | $5.52M 10-K · filed 2025-03-05 | $4.22M 10-K · filed 2023-02-22 |
| 2022-09-30 | $1.79M 10-Q · filed 2023-11-03 | $2.34M derived: sum of 2 quarters · filed 2023-11-03 | $2.81M 10-Q · filed 2023-11-03 | $2.98M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $546.00K 10-Q · filed 2023-08-02 | $1.01M 10-Q · filed 2023-08-02 | $1.19M derived: sum of 3 quarters · filed 2024-02-28 | $1.34M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $469.00K 10-Q · filed 2023-05-05 | $644.00K derived: sum of 2 quarters · filed 2024-02-28 | $796.00K derived: sum of 3 quarters · filed 2024-02-28 | $942.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $327.00K derived: sum of 2 quarters · filed 2024-02-28 | $473.00K derived: sum of 3 quarters · filed 2024-02-28 | $607.00K 10-K · filed 2024-02-28 | $2.34M 10-K · filed 2022-02-24 |
| 2021-09-30 | $152.00K 10-Q · filed 2022-11-02 | $298.00K derived: sum of 2 quarters · filed 2022-11-02 | $432.00K 10-Q · filed 2022-11-02 | $660.00K derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $146.00K 10-Q · filed 2022-08-03 | $280.00K 10-Q · filed 2022-08-03 | $508.00K derived: sum of 3 quarters · filed 2023-02-22 | $734.00K derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $134.00K 10-Q · filed 2022-05-04 | $362.00K derived: sum of 2 quarters · filed 2023-02-22 | $588.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.18M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $454.00K derived: sum of 2 quarters · filed 2023-02-22 | $1.05M derived: sum of 3 quarters · filed 2023-02-22 | $2.60M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $226.00K 10-Q · filed 2021-11-09 | $818.00K derived: sum of 2 quarters · filed 2021-11-09 | $2.38M 10-Q · filed 2021-11-09 | $4.02M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $592.00K 10-Q · filed 2021-08-05 | $2.15M 10-Q · filed 2021-08-05 | $3.80M derived: sum of 3 quarters · filed 2022-02-24 | $5.48M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $1.56M 10-Q · filed 2021-05-06 | $3.20M derived: sum of 2 quarters · filed 2022-02-24 | $4.88M derived: sum of 3 quarters · filed 2022-02-24 | $6.82M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.33M derived: sum of 2 quarters · filed 2022-02-24 | $5.26M derived: sum of 3 quarters · filed 2022-02-24 | $7.31M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-06 | $3.61M derived: sum of 2 quarters · filed 2020-11-06 | $5.67M 10-Q · filed 2020-11-06 | $6.87M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $1.93M 10-Q · filed 2020-08-07 | $3.99M 10-Q · filed 2020-08-07 | $5.19M derived: sum of 3 quarters · filed 2021-02-26 | $6.21M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $2.06M 10-Q · filed 2020-05-08 | $3.26M derived: sum of 2 quarters · filed 2021-02-26 | $4.28M derived: sum of 3 quarters · filed 2021-02-26 | $5.06M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.23M derived: sum of 2 quarters · filed 2021-02-26 | $3.01M derived: sum of 3 quarters · filed 2021-02-26 | $3.44M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $1.02M 10-Q · filed 2019-11-12 | $1.80M derived: sum of 2 quarters · filed 2019-11-12 | $2.24M 10-Q · filed 2019-11-12 | $2.37M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | $780.00K 10-Q · filed 2019-08-07 | $1.22M 10-Q · filed 2019-08-07 | $1.34M derived: sum of 3 quarters · filed 2020-02-26 | $1.30M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $438.00K 10-Q · filed 2019-05-08 | $562.00K derived: sum of 2 quarters · filed 2020-02-26 | $516.00K derived: sum of 3 quarters · filed 2020-02-26 | $70.00K derived: sum of 4 quarters · filed 2020-02-26 | |
| 2017-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $78.00K derived: sum of 2 quarters · filed 2020-02-26 | -$368.00K derived: sum of 3 quarters · filed 2020-02-26 | -$978.00K 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$46.00K 10-Q · filed 2018-11-08 | -$492.00K derived: sum of 2 quarters · filed 2018-11-08 | -$1.10M 10-Q · filed 2018-11-08 | -$1.46M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$446.00K 10-Q · filed 2018-08-07 | -$1.06M 10-Q · filed 2018-08-07 | -$1.41M derived: sum of 3 quarters · filed 2019-03-01 | -$1.27M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$610.00K 10-Q · filed 2018-05-04 | -$967.00K derived: sum of 2 quarters · filed 2019-03-01 | -$825.00K derived: sum of 3 quarters · filed 2019-03-01 | -$672.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$215.00K derived: sum of 2 quarters · filed 2019-03-01 | -$62.00K derived: sum of 3 quarters · filed 2019-03-01 | $62.00K 10-K · filed 2019-03-01 | |
| 2016-09-30 | $142.00K 10-Q · filed 2017-11-08 | $295.00K derived: sum of 2 quarters · filed 2017-11-08 | $419.00K 10-Q · filed 2017-11-08 | $385.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | $153.00K 10-Q · filed 2017-08-09 | $277.00K 10-Q · filed 2017-08-09 | $243.00K derived: sum of 3 quarters · filed 2018-03-08 | $199.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | $124.00K 10-Q · filed 2017-05-15 | $90.00K derived: sum of 2 quarters · filed 2018-03-08 | $46.00K derived: sum of 3 quarters · filed 2018-03-08 | $12.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2015-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$78.00K derived: sum of 2 quarters · filed 2018-03-08 | -$112.00K derived: sum of 3 quarters · filed 2018-03-08 | -$143.00K 10-K · filed 2018-03-08 | |
| 2015-09-30 | -$44.00K 10-Q · filed 2016-11-09 | -$78.00K derived: sum of 2 quarters · filed 2016-11-09 | -$109.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | -$34.00K 10-Q · filed 2016-08-10 | -$65.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | -$31.00K 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | -$34.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |